D
Olema Pharmaceuticals, Inc. OLMA
$3.06 -$0.12-3.77%
Recommendation
Sell
Prev Close
$3.18
Volume
779,596
Avg Vol (90D)
1,093,160
Market Cap
$217.30M
Dividend & Yield
--
52-Week Range
$2.86 - $16.62
P/E (TTM)
--
EPS (TTM)
-$2.21
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market
4/8/2025 - SeekingAlpha
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market
4/8/2025 - Seeking Alpha - Long Ideas
Pictet Asset Management Holding SA Boosts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
4/4/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $3.33) Aroon Indicator entered a Downtrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2/2025 - Globe Newswire
Olema Pharmaceuticals (OLMA, $3.34) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 1, 2025
4/2/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.34) Aroon Indicator entered a Downtrend on April 01, 2025.
4/2/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.76) Aroon Indicator entered a Downtrend on March 31, 2025.
4/1/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.76) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop
4/1/2025 - Simply Wall St
Analysts' Top Healthcare Picks: Olema Pharmaceuticals (OLMA), Connect Biopharma Holdings (CNTB)
4/1/2025 - TipRanks Financial Blog
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
3/31/2025 - MarketBeat
JPMorgan Chase & Co. Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00
3/29/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $4.11) Aroon Indicator entered a Downtrend on March 28, 2025.
3/29/2025 - Tickeron - Technical Analysis
Olema Pharmaceuticals (OLMA, $4.2) Aroon Indicator entered a Downtrend on March 27, 2025.
3/28/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $4.14) Aroon Indicator entered a Downtrend on March 26, 2025.
3/27/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $4.19) Aroon Indicator entered a Downtrend on March 25, 2025.
3/26/2025 - Tickeron - Stocks
Pier Capital LLC Invests $1.59 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
3/26/2025 - MarketBeat
Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
3/25/2025 - Globe Newswire
Olema Pharmaceuticals (OLMA, $4.32) Aroon Indicator entered a Downtrend on March 24, 2025.
3/25/2025 - Tickeron - Stocks
VTWG's Underlying Holdings Could Mean 36% Gain Potential
3/24/2025 - ETF Channel
FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital
3/22/2025 - MarketBeat
HC Wainwright Issues Optimistic Estimate for OLMA Earnings
3/22/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $4.23) Aroon Indicator entered a Downtrend on March 21, 2025.
3/22/2025 - Tickeron - Stocks
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
3/22/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$141.87M
EBIT (TTM)
-$142.26M
Net Income (TTM)
-$129.47M
Balance Sheet
Total Assets (Q)
$450.98M
Total Debt (Q)
$1.43M
Total Liabilities (Q)
$42.02M
Book Value Per Share (Q)
$5.50
Cash Flow
Cash from Operations (TTM)
-$104.35M
Cash from Investing (TTM)
-$93.53M
Cash from Financing (TTM)
$268.82M
Net Change in Cash (TTM)
$70.94M
Filings
Filing Date
Tuesday, March 18, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.30
7-Day Total Return
-25.55%
30-Day Total Return
-34.33%
60-Day Total Return
-39.29%
90-Day Total Return
-65.66%
Year to Date Total Return
-45.06%
1-Year Total Return
-72.85%
2-Year Total Return
-6.71%
3-Year Total Return
-15.00%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $2.86
52-week High
Aug 01, 2024 - $16.62
Valuation
Market Cap
$217.30M - Micro Cap
Enterprise Value
-$215.36M
Price/Sales (TTM)
--
Price/Book (Q)
0.58
Dividends and Shares
Shares Outstanding
65.79M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
olema.com
Phone Number
415 651 3316
Address
780 Brannan Street
San Francisco, CA 94103
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. The company’s lead product... more
NASDAQ 04/08/2025 4:00PM Eastern Quotes delayed
Weiss Ratings